Put companies on watchlist
AEVIS VICTORIA SA
ISIN: CH0478634105
WKN: A2PLW7
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

AEVIS VICTORIA SA · ISIN: CH0478634105 · EQS - Company News (73 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 2108620
31 March 2025 07:00AM

AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025


AEVIS VICTORIA SA / Key word(s): Annual Results
AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025

31.03.2025 / 07:00 CET/CEST


Press release

Fribourg, 31 March 2025

Infracore strengthens its balance sheet and prepares for accelerated growth in 2025

Infracore SA, a leading Swiss healthcare infrastructure company, today reports solid results for the financial year 2024, marked by continued portfolio expansion, strategic deleveraging and a clear roadmap for growth.

2024 Results: Solid performance and strong financial foundations
Infracore posted rental income of CHF 60.5 million, up from CHF 59.6 million in 2023. The company delivered an EBITDA of CHF 59.5 million, representing a robust 90.4% margin. Net profit for the year came in at CHF 33.7 million, slightly lower than the previous year due to an increase in deferred tax expenses. Earnings per share (EPS) amounted to CHF 2.90.

A key highlight was the full repayment of a CHF 100 million bond, significantly reducing the Loan-to-Value (LTV) ratio from 48.0% to 43.3%. The Net Asset Value (NAV) after taxes increased to CHF 600 million, up 6% year-on-year.

A unique track record in hospital infrastructure
Since 2006, Infracore has built up unmatched expertise in the construction, renovation and modernization of hospital sites across Switzerland. With more than 35 projects completed, Infracore is today the country’s leading hospital real estate specialist.

Until now, the company has focused primarily on Swiss Medical Network assets. Moving forward, it intends to offer its know-how to other Swiss healthcare providers, public or private, leveraging its operational, financial and regulatory experience to support their infrastructure transformation.

Genolier Innovation Hub and portfolio expansion
The company’s investment property portfolio increased by CHF 28 million and nearly reached the CHF 1.33 billion mark in 2024, driven by the completion of the Genolier Innovation Hub, a pioneering facility dedicated to medical innovation, training and research. Major investments were also made across the Bethanien, Valmont and Ars Medica sites, contributing to the value growth of the portfolio.

Outlook 2025: Acceleration on all fronts
Infracore expects a strong increase in rental income in 2025, supported by the delivery of ongoing projects. In addition, the company plans to integrate new properties valued at nearly CHF 100 million. This expansion is backed by a capital increase fully subscribed by existing shareholders, reaffirming their long-term commitment to Infracore’s strategy.

“With a reinforced portfolio, significantly reduced leverage and a solid pipeline, Infracore is uniquely positioned to support the ongoing transformation of Switzerland’s healthcare sector,” said Eric Frey, CEO of Infracore SA.

For more information:  
Media and investor relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, prb@dynamicsgroup.ch, +41 79 785 46 32
Infracore SA: info@infracore.ch, +41 79 635 04 10

About Infracore SA
Infracore SA is a Swiss healthcare infrastructure company. Its real estate portfolio consists of 47 quality properties situated on 19 prime locations across Switzerland, representing a total rental surface over 206’000 sqm. The market value of Infracore's portfolio is estimated at CHF 1.33 billion. Infracore is positioning itself as a partner of public or private institutions for real estate investments and intends to play a key role in the reshaping of the Swiss hospital landscape. Infracore is jointly controlled by Medical Properties Trust, Inc. and AEVIS VICTORIA SA. www.infracore.ch.

About Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world’s largest owners of hospital real estate with 396 facilities and approximately 39’000 licensed beds in nine countries and across three continents as of December 31, 2024. MPT’s financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. www.medicalpropertiestrust.com.

About AEVIS VICTORIA SA
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network Holding SA (76.3%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, MRH Switzerland AG, a luxury hotel group managing eleven hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.



End of Media Release


2108620  31.03.2025 CET/CEST

Visual performance / price development - AEVIS VICTORIA SA
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.